The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel prognostic risk classification model for NUT midline carcinoma: a largest cohort analysis from the NMC registry.
 
Nicole Grace Chau
Research Funding - GlaxoSmithKline; Merck (Inst); Pfizer (Inst)
 
Clement Ma
Employment - PatientsLikeMe (I)
Research Funding - GlaxoSmithKline
 
Kristina Danga
No Relationships to Disclose
 
Hasan Al-Sayegh
Research Funding - GlaxoSmithKline (Inst)
 
Madhumitha Sridharan
Research Funding - GlaxoSmithKline (Inst)
 
Valentina Nardi
Stock and Other Ownership Interests - KSQ Therapeutics (I); Navicor (I)
Consulting or Advisory Role - CALORICS (I); Cell Signaling Technology (I); RAZE (I); Thermo Fisher Scientific (I)
 
Ryan Barrette
No Relationships to Disclose
 
Christopher Lathan
No Relationships to Disclose
 
Steven G. DuBois
Honoraria - Loxo
Consulting or Advisory Role - Loxo
Research Funding - Curis (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Loxo; Roche/Genentech
 
Robert I. Haddad
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Merck (Inst); VentiRx (Inst)
 
Geoffrey Shapiro
Consulting or Advisory Role - G1 Therapeutics; Lilly; Merck Serono; Pfizer; Roche; Sierra Oncology
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); CanBas (Inst); Cellceutix (Inst); Covidien (Inst); Curis (Inst); Cyclacel (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly; Lilly (Inst); Merck Serono; Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); Puma Biotechnology (Inst); Roche (Inst); Sanofi (Inst); Sierra Oncology; Syros Pharmaceuticals (Inst); Tensha Therapeutics (Inst); Tesaro (Inst); Vertex (Inst)
 
Stephen E. Sallan
No Relationships to Disclose
 
Arindam Dhar
Employment - GlaxoSmithKline
 
Jeanenne Joy Nelson
Employment - GlaxoSmithKline
 
Christopher Alexander French
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - Constellation Pharmaceuticals; Curis; GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - Brigham and Women's Hospital